SMAD4 (NM_005359) Human Tagged ORF Clone
SMAD4 (Myc-DDK-tagged)-Human SMAD family member 4 (SMAD4)
|Type||Human Tagged ORF Clone|
|Synonyms||DPC4; JIP; MADH4; MYHRS|
|E. coli Selection||Kanamycin (25 ug/mL)|
|Mammalian Cell Selection||Neomycin|
>RC201828 representing NM_005359
Red=Cloning site Blue=ORF Green=Tags(s)
>RC201828 representing NM_005359
Red=Cloning site Green=Tags(s)
Sequencher program is needed, download here.
|Restriction Sites||SgfI-MluI Cloning Scheme for this gene Plasmid Map|
|ORF Size||1656 bp|
|OTI Disclaimer||The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info|
|OTI Annotation||This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.|
|Product Components||The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).|
|Reconstitution||1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
|RefSeq Size||3220 bp|
|RefSeq ORF||1659 bp|
|Domains||DWB, DWA, MH1|
|Protein Families||Druggable Genome, Transcription Factors|
|Protein Pathways||Adherens junction, Cell cycle, Chronic myeloid leukemia, Colorectal cancer, Pancreatic cancer, Pathways in cancer, TGF-beta signaling pathway, Wnt signaling pathway|
|Gene Summary||This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasng blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, Aug 2017]|
|cDNA Clone Resources|
|RC201828L1||Lenti ORF clone of Human SMAD family member 4 (SMAD4), Myc-DDK-tagged||
|RC201828L2||Lenti ORF clone of Human SMAD family member 4 (SMAD4), mGFP tagged||
|RC201828L3||Lenti ORF clone of Human SMAD family member 4 (SMAD4), Myc-DDK-tagged||
|RC201828L4||Lenti ORF clone of Human SMAD family member 4 (SMAD4), mGFP tagged||
|RG201828||SMAD4 (GFP-tagged) - Human SMAD family member 4 (SMAD4)||
|SC116771||SMAD4 (untagged)-Human SMAD family member 4 (SMAD4)||